tiprankstipranks
Cellectis SA (CLLS)
NASDAQ:CLLS

Cellectis SA (CLLS) Stock Investors

856 Followers
Based on 730,199 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLLS
On average, investors allocate 0.00% of their portfolios to CLLS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLLS

1.4%
Last 7
Days
5.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLLS, out of 730,199 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLLS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.67%
$2.54
Based on the activity of 13,714 investors who made their portfolios public
The table shows changes in CLLS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLLS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.67%
-1.40%
-8.90%
247.43M
Healthcare
Block
4.51%
-0.83%
-7.83%
46.31B
Technology
Trade Desk
4.63%
-0.03%
-4.95%
39.64B
Technology
Micron
5.71%
+0.54%
+7.08%
124.53B
Technology
Merck & Company
4.12%
+0.09%
-1.16%
321.34B
Healthcare
Mercadolibre
5.27%
-0.71%
-2.75%
70.72B
Consumer Cyclical
GE Aerospace
5.54%
+2.08%
+8.36%
177.79B
Industrials
Marvell
4.79%
+0.63%
+4.97%
55.30B
Technology
ChargePoint Holdings
3.88%
-1.04%
-7.27%
567.30M
Consumer Cyclical
Marathon Digital Holdings
5.64%
+0.31%
-2.68%
5.49B
Financial
Based on the activity of 730,199 active portfolios
Open your Smart Portfolio

CLLS Investor Analysis

CLLS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.0%
of CLLS holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
CLLS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
55.8%
of CLLS holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
CLLS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.2%
of CLLS holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of CLLS stock investors
See who invests in CLLS according to age group and performance.

FAQ

How many retail Investors hold CLLS?
<0.1% of TipRanks' retail investors hold CLLS in their portfolios.
    What is CLLS Investor Sentiment?
    CLLS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CLLS in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of CLLS in the last 7 days.
        What percentage of retail investors changed their holding of CLLS in the last 30 days?
        ▼ 5.7% of TipRanks' retail investors changed their holding of CLLS in the last 30 days.
          What is the average age of retail investors who hold CLLS?
          The average age of CLLS Holders is between 35–55.
            What other stocks have CLLS investors also bought?
            CLLS Investors also bought CHRS, SQ, TTD, MU, MRK, MELI, GE, MRVL, CHPT, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              GERNGeron
              HCAHCA Healthcare
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis